(Circulation. 1997;96:1078-1081.)
© 1997 American Heart Association, Inc.
Articles |
From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Department of Cardiology, Children's Hospital, Harvard Medical School (R.K, B.S., P.S., K.L.), Boston, Mass; the Department ofClinical Pharmacology, Benjamin Franklin Hospital (R.K., N.H., D.G.), Berlin, Germany; and the Max Delbrück Centre for Molecular Medicine (D.G., K.L.), Berlin, Germany.
Correspondence to Klaus Lindpaintner, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St - Thorn 1103, Boston, MA 02115. E-mail kl{at}calvin.bwh.harvard.edu
| Abstract |
|---|
|
|
|---|
Methods and Results We measured BP and HR in SHRSPHD and normotensive Wistar-Kyoto rats (WKY), as well as in F2 hybrids bred from crossing the two strains, at baseline and after 12 days of dietary NaCl loading. Random marker genome screening and cosegregation analysis were performed on F2 hybrids derived from SHRSPHD/WKY-0HD (n=115) and SHRSPHD/WKY-1HD (n=139) crosses (WKY-0HD and WKY-1HD are two congenic WKY strains). HR in SHRSPHD was significantly higher than in WKY-0HD both at baseline (404±30 versus 375±46 bpm; P=.0034) and after NaCl (437±23 versus 364±40 bpm; P=10-9). BP in F2 hybrids showed no significant correlation with HR either at baseline or after NaCl loading. HR after NaCl loading but not at baseline was significantly linked in a recessive fashion to a locus on chromosome 3: in animals homozygous for the SHRSPHD allele, HR was 414±49 compared with 383±44 bpm in heterozygotes and WKY homozygotes (F210,1=19.7, P=1.4x10-5, lod score=5.9). The putative BP-relevant gene at this locus, termed HR-SP1, showed no evidence of linkage to any of the BP parameters measured.
Conclusions Our results demonstrate that a genetic locus on rat chromosome 3, HR-SP1, contributes directly to the regulation of HR in SHRSPHD but exhibits no effect on BP. Thus, in addition to its modulation by reflex-mediated neurohumoral mechanisms, HR is also under the direct influence of primary genetic factors.
Key Words: genes hypertension heart rate blood pressure
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
BP Measurement
The protocol for the hemodynamic
characterization of the F2 rats and the WKY-0HD
and SHRSPHD progenitor strains (n=11 and 12 males and
females, respectively) was identical. It included femoral artery
cannulation and intermittent on-line recordings as reported
previously.10 Two consecutive femoral artery cannulations
to measure BP and HR at baseline and after a period of 12 days of
dietary NaCl exposure (1% NaCl in the drinking water) were
performed.10 During measurements, the animals were
shielded from the investigator, and three independent readings were
taken while the animals were resting quietly.10
Genotype Determination
A total genome screen was performed using polymorphic SSLPs
(microsatellites: stretches of repetitive DNA that tend to be unstable,
thus often polymorphic, ie, different from strain to strain, and
thus useful for genetic mapping) obtained from previously published
panels of SSLPs,7 8 11 12 from new library
screenings,11 and from GenBank data searches. SSLP markers
were amplified by PCR from 50 ng of genomic DNA in a final reaction
volume of 10 µL, containing 100 nmol/L of each primer,
200 µmol/L dNTPs, 1.5 mmol/L
MgCl2, 50 mmol/L KCl, 10 mmol/L
Tris-HCl (pH 9.0 at 25°C), 0.1% Triton X-100, and 0.25 U of
Taq DNA polymerase. The forward primer was labeled with
[
-32P]ATP (specific activity of 3000 Ci ·
mmol-1, DuPont/NEN) using T4
polynucleotide kinase (NEB). PCR reactions were processed
on an MJ Research thermal cycler (PTC 100) using the following
protocol: initial denaturation at 92°C for 3 minutes followed by 30
cycles of denaturation at 92°C for 15 seconds, annealing at 55°C
for 1 minute, and extension at 72°C for 1 minute, followed by a final
extension step at 72°C for 7 minutes. Subsequent to the PCR, the
samples were analyzed by polyacrylamide gel
electrophoresis and autoradiography as described
previously.7
Statistical Analysis and Linkage Analysis
Interstrain comparisons were performed by two-way ANOVA to test
the effects of strain and sex. Statistical evaluation of the effect of
genotypes on HR phenotype in the F2
intercrosses was performed by ANCOVA) to account for sex, cross, and
parental constellation of the reciprocal crosses and to adjust for BP,
respectively. For combined linkage analysis in both
F2 intercrosses, means in each group were adjusted for
cross, sex, and reciprocal cross status where
appropriate.7 Linear regression analysis was
performed by calculating the coefficient of determination,
R2. Chromosomal mapping and lod score
calculations were performed using the MAPMAKER/EXP and MAPMAKER/QTL
programs.13 All phenotype parameters
are expressed as mean±SD.
| Results |
|---|
|
|
|---|
|
In both F2 cohorts, no significant correlation between
systolic or diastolic BP and HR was observed either
at baseline (R2=.09, P=.15 and
R2=.02, P=.64, respectively) or after
NaCl loading (R2=-.06, P=.35 and
R2=-.10, P=.14, respectively). The
genome screen identified suggestive linkage between a marker on
chromosome 3 (Scn2a1) and HR after NaCl loading in both
F2 crosses. ANCOVA revealed no significant differences
between WKY homozygotes and heterozygotes. Accordingly, under
assumptions of a recessive mode of inheritance (both alleles must
carry the "mutant" genotype), zygosity (ie, constellation
of alleles) at Scn2a1 demonstrated significant linkage
to HR after NaCl loading in the
F2(WKY-0HDxSHRSPHD)
(P=.0062) and the
F2(WKY-1HDxSHRSPHD)
(P=.0012) populations. Basal HR showed evidence for linkage
to the same locus in the
F2(WKY-1HDxSHRSPHD)
(P=.0008) cohort but not in the other cross
(P=.33). Analysis for HR and BP phenotypes
in both crosses combined demonstrated highly significant linkage
between Scn2a1 and HR after NaCl loading (Table 2
). In animals homozygous (ie, carrying
two identical alleles) for the SHRSP allele, HR was
30 bpm
higher than in heterozygotes (ie, carrying one allele each from the
progenitor strains) or WKY homozygotes. A maximum lod score of 5.9 was
observed by QTL mapping, yielding a 100:1 CI for placement of the
implicated gene, HR-SP1, that spans 32 cM
(Figure
). HR-SP1 accounted for
14% of the overall variance of HR after NaCl loading. As expected, no
linkage was found between BP phenotypes and HR-SP1
(Table 2
). Adjustment for BP by ANCOVA had no effect on the linkage
data for HR-SP1 and HR either at baseline or after NaCl
loading (data not shown).
|
|
| Discussion |
|---|
|
|
|---|
The lack of correlation between HR and BP phenotypes in our analysis argues against a causal contribution of increased HR to hypertension in SHRSP at the developmental stage examined. It also rules out the possibility that the observed alteration of HR in SHRSP is a secondary, hypertension-induced event. The genome screening analysis, on the other hand, demonstrated that HR variance is, at least in part, directly determined by the influence of a genetic locus, HR-SP1, on rat chromosome 3. Allelic status at HR-SP1 was not associated with differences in BP, and adjustment for BP before linkage analysis had no effect on the results. These data indicate that the influence of HR-SP1 was maintained across the entire range of blood pressures (136 to 210 mm Hg systolic) observed in the F2 crosses.
The finding that significant linkage to HR-SP1 in the overall population was only detected after oral NaCl loading may point to an ecogenetic (gene-environment) interaction between HR-SP1 and dietary NaCl content. Alternatively, the failure to obtain overall significant linkage to HR-SP1 at baseline may be attributed to a higher environmental noise present during normal salt intake that may act as a confounder, preventing the detection of the HR-SP1 effect under normal dietary conditions.7
The presence of the gene that encodes the brain isoform of the
-1
polypeptide of the type 2 voltage-gated sodium channel
(Scn2a1) at the center of the HR-SP1 locus
allowed the identification of a homologous region on human chromosome
2q23-2q24.3.18 This segment carries the human
SCN2A gene and exhibits conservation with a corresponding
region on mouse chromosome 2.19 Interestingly, the gene
encoding a human G-proteincoupled, inwardly rectifying K+
channel, GIRK1, was recently mapped to human chromosome
2q24.1.20 GIRK1 represents one of the
two inwardly rectifying K+ channel subunits that make up
KACh, which is involved in HR regulation in response to
vagal stimulation via activation of muscarinic
receptors.21 Therefore, we may speculate that the rat
homologue of GIRK1, Kir3.4, may represent a
candidate gene for HR-SP1, even though one obviously needs
to be mindful of the fact that the 100:1 CI for mapping
HR-SP1 spans a genetic distance of 32 cM. This is a segment
large enough to be expected to contain some 1500 genes, among which
multiple other candidate genes may be present. Analysis of
the currently available homology data for human, mouse, and rat
revealed no other plausible candidate genes.
At present, without knowledge of the nature of the relevant gene at HR-SP1 and in the absence of information concerning a large number of potentially interesting intermediate phenotypes that relate to HR, we can only speculate whether the effect of HR-SP1 is a "direct" one (eg, a mutation affecting the cardiac pacemaker channel) or a more "remote" phenomenon (eg, mediated via modulation/resetting of one of the complex regulatory circuits that modulate cardiovascular function). We can say with certainty, however, that the portion of HR variance determined by HR-SP1 is not correlated nor collinear with BP and therefore is not a function of resetting the threshold or gain of classic pathways.
As is always the case in experiments of this kind, any conclusions and generalizations from these results regarding the effects of HR-SP1 must be made with great caution. Strictly speaking, our data and interpretations apply only to the strains and crosses as well as the particular experimental settings examined and, equally important, only to the specific developmental period under investigation in this study. Therefore, we cannot exclude the possibility that at a different developmental stage HR, and thus genes affecting HR regulation, may contribute to BP variance in SHRSPHD.
In summary, our study provides the first evidence that allelic variation at an HR-relevant genetic locus has the potential to affect HR in a primary, direct fashion that is independent of BP. Moreover, it provides the first example of identifying such an HR-relevant genetic locus by means of linkage analysis. Our data highlight the power of dissecting complex cardiovascular traits by molecular genetic means. Continued efforts along this line of investigation will lead to a better understanding of the complex interplay of heritable and environmental factors and of primary genetic and secondary, reflex-mediated mechanisms that govern cardiovascular function.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received May 16, 1997; revision received June 4, 1997; accepted June 6, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Howden, E. Liu, L. Miller-DeGraff, H. L. Keener, C. Walker, J. A. Clark, P. H. Myers, D. C. Rouse, T. Wiltshire, and S. R. Kleeberger The genetic contribution to heart rate and heart rate variability in quiescent mice Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H59 - H68. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Martin, A. G. Comuzzie, G. E. Sonnenberg, J. Myklebust, R. James, J. Marks, J. Blangero, and A. H. Kissebah Major Quantitative Trait Locus for Resting Heart Rate Maps to a Region on Chromosome 4 Hypertension, May 1, 2004; 43(5): 1146 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tavazzi Heart rate as a therapeutic target in heart failure? Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G15 - G18. [Abstract] [PDF] |
||||
![]() |
F. Sugiyama, G. A. Churchill, R. Li, L. J. M. Libby, T. Carver, K.-I. Yagami, S. W. M. John, and B. Paigen QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice Physiol Genomics, July 12, 2002; 10(1): 5 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jaworski, M. Jirout, S. Closson, L. Breen, P. L. Flodman, M. A. Spence, V. Kren, D. Krenova, M. Pravenec, and M. P. Printz Heart Rate and Blood Pressure Quantitative Trait Loci for the Airpuff Startle Reaction Hypertension, February 1, 2002; 39(2): 348 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft and A. Busjahn Peaks and Valleys Hypertension, July 1, 2001; 38(1): 38 - 40. [Full Text] [PDF] |
||||
![]() |
J. DUTIL and A. Y. DENG Further chromosomal mapping of a blood pressure QTL in Dahl rats on chromosome 2 using congenic strains Physiol Genomics, June 6, 2001; 6(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Singh, M. G. Larson, C. J. O'Donnell, H. Tsuji, J. C. Evans, and D. Levy Heritability of Heart Rate Variability : The Framingham Heart Study Circulation, May 4, 1999; 99(17): 2251 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Kim, C. I. Kiefe, K. Liu, O. D. Williams, D. R. Jacobs Jr, and A. Oberman Heart Rate and Subsequent Blood Pressure in Young Adults : The CARDIA Study Hypertension, February 1, 1999; 33(2): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |